This compact Chinese device can detect cancer biomarkers in a drop of blood

A groundbreaking development in cancer diagnostics promises to detect early-stage cancer using just a single drop of blood. Wen Liaoyong and his team at Westlake University in Hangzhou, China, have successfully miniaturized a detection system, compressing what was once refrigerator-sized into a handheld device.

This innovative technology not only boasts a significantly reduced physical footprint but also achieves remarkable accuracy, reportedly about 10,000 times greater than conventional methods. The findings, published in the prestigious journal Nature Photonics on May 13, represent a major leap forward in diagnostic capabilities.

Wen, who joined Westlake University's school of engineering in 2019, focuses his research on novel multi-component nanostructured materials and their diverse applications. His team's work establishes a "scalable and robust nanophotonic biosensing paradigm," as described in the paper's introduction. This paradigm is designed for miniaturized, high-performance diagnostics suitable for various settings, including clinical environments, remote locations, and even at-home use.

The implications of this technology are vast, potentially revolutionizing cancer screening by making it more accessible, faster, and more accurate. Early detection is often critical in improving patient outcomes and treatment effectiveness, and this compact device could play a pivotal role in achieving that goal.

“

This work establishes a scalable and robust nanophotonic biosensing paradigm for miniaturised, high-performance diagnostics in clinical, remote and at-home settings.